Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
RGNXCompany Name
REGENXBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQREGENXBIO INC - Enterprise Value over Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RGNX - EV/FCF Historical data
| Date | Enterprise Value | Enterprise Value over Free Cash Flow | Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 589.17M | 0 | $ -90.71M |
| 3/31/2025 | $ 401.17M | 0 | $ -86.94M |
| 12/31/2024 | $ 410.23M | 0 | $ -175.56M |
| 9/30/2024 | $ 554.37M | 0 | $ -184.74M |
| 6/30/2024 | $ 756.74M | 0 | $ -194.72M |
| 3/31/2024 | $ 876.66M | 0 | $ -198.64M |
| 12/31/2023 | $ 1.04B | 0 | $ -228.37M |
| 9/30/2023 | $ 863.15M | 0 | $ -231.32M |
| 6/30/2023 | $ 967.91M | 0 | $ -235.98M |
| 3/31/2023 | $ 1.03B | 0 | $ -257.07M |
Key Performance Insights, Last 5 Years
- REGENXBIO INC's latest trailing twelve months (TTM) EV/FCF stands at 0.
- Over the past 5 years, REGENXBIO INC's average EV/FCF has been 9.76.
- The median EV/FCF for REGENXBIO INC during this period was 8.93
- REGENXBIO INC reached its highest EV/FCF over the past 5 years at 13.39.
- The lowest EV/FCF recorded by REGENXBIO INC in the same timeframe 7.77
REGENXBIO INC's EV/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/FCF Benchmarks
Similar metrics to FCF:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
Definition of Enterprise Value over Free Cash Flow
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].EV / FCF
(=) EV/FCF EV/FCF for REGENXBIO INC is calculated as follows: EV [ $ 1.13B ] / FCF [ $ -134.05M ]
(=) EV/FCF [ 0 ] RGNX - Enterprise Value over Free Cash Flow, Last 5 years
7.77
Minimum
Dec 31, 2021
13.39
Maximum
Jun 30, 2022
9.76
Average
8.93
Median
EV/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of EV/FCF for companies in the Total Stock Market. The average EV/FCF of the companies is 23.44 with a standard deviation of 16.12.
The following table provides additional summary stats:
EV/FCF in the Market:
| filtered constituents | 2.2K |
|---|---|
| min | 0.05 |
| max | 77.98 |
| average | 23.44 |
| median | 19.08 |
| std | 16.12 |